Latest News

These companies will do well no matter what happens in the AI landscape.

Record cannabis sales came with pressure from trim pricing and Canadian brands.

Tokenized offerings expand as capital shifts toward AI data center projects.

How much should you invest in RioCan for $300 a month in dividends? Explore its retail business, monthly payout and the investment needed.

CAMP4 Therapeutics (NASDAQ:CAMP) expects initial data from its SYNGAP1 clinical program in the first half of 2028, as the company prepares to begin dosing patients with a treatment designed to increase expression of a gene associated with a rare neurological disorder. Chief Executive Officer Josh M

Trade Desk (NASDAQ:TTD) reported third-quarter revenue of $736 million, down 0.5% from a year earlier but above its August outlook, as political advertising and demand from medical and health clients helped lift results. The advertising technology company also benefited from a nonrecurring transact

GeneDx (NASDAQ:WGS) reported third-quarter revenue of $123.1 million and raised its full-year profitability outlook, even as new documentation requirements led the genetic testing company to lower its expectations for test volume growth. Management said the company is requiring more payer documenta

Quantum Computing (NASDAQ:QUBT) reported record third-quarter 2026 revenue of $9.5 million, driven primarily by its expanded photonics business, while its net loss widened as the company increased spending on personnel, research and commercialization. Revenue rose from $384,000 a year earlier and e

WEBTOON Entertainment (NASDAQ:WBTN) reported a 4% decline in third-quarter revenue as currency headwinds and weaker results in Japan offset growth in advertising and its Korean business. The company forecast a return to double-digit revenue growth on a constant-currency basis in the fourth quarter.

Quantum (NASDAQ:QMCO) reported fiscal second-quarter revenue of $89.6 million, up 43% from a year earlier, as demand for its secondary storage products helped push its backlog to nearly $100 million. The company also posted adjusted EBITDA of $11.1 million for the quarter ended September 30, 2026,

Sanmina (NASDAQ:SANM) forecast fiscal 2027 revenue of $17.5 billion to $19.5 billion as it begins shipping AMD’s Helios accelerated-compute systems and prepares to ramp additional cloud and artificial intelligence programs. The outlook followed a fiscal fourth quarter in which revenue rose 84% from

Qualys (NASDAQ:QLYS) reported 11% revenue growth for the third quarter of 2026 and raised its full-year earnings outlook, as federal customer wins helped drive a second consecutive quarter of double-digit growth in calculated current billings. Revenue rose to $188 million, while non-GAAP earnings w

Hyperfine (NASDAQ:HYPR) reported record third-quarter revenue and gross margin, while narrowing its operating loss and reducing cash burn as sales of its portable brain MRI system increased across its U.S. and international markets. Revenue rose 73% from a year earlier to $6 million for the quarter

PubMatic (NASDAQ:PUBM) reported 17% year-over-year revenue growth in the third quarter of 2026, marking its third consecutive quarter of accelerating growth as connected TV, mobile app advertising and newer products drove gains. Adjusted EBITDA more than doubled to $26 million, with a margin of 33%

AbCellera Biologics (NASDAQ:ABCL) plans to advance its experimental hot flash treatment ABCL635 into late-stage development in 2027 after reporting positive mid-stage results, while shelving further development of a separate antibody candidate for now. On its third-quarter earnings call, the compan

Pilot Water and Peak Rentals moves reshape Select Water's outlook.

Immunovant drops Sjögren's and points to 2027 readouts.

Hospital uptake peaked as a subcutaneous version moves toward quarterly dosing.

Fintech and fiber growth lifted results, though data center demand slowed.

Net leverage fell to 2.3x while AppGrowth revenue climbed 42% this quarter.

Management details the shift from research toward scalable, commercial manufacturing.

Phase 3 wins set up a 2027 filing and a commercial push.

Explore the latest insights on Telus dividend amid a challenging earnings report and management's new Transformation Strategy.

Waste Connections earns my interest for a 10-year TFSA, with recurring demand and cash generation balanced against a demanding valuation.

Alphabet’s sharp sell-off raises a big question: Are investors more concerned about AI spending than AI growth?